Menu Close

Trending

Data backs AZ’s Wilson disease drug, but with a question mark
Fujifilm acquires AI tech to improve fertility treatment
Sarepta shares yo-yo as FDA places hold on Duchenne trial
New countries stockpile antiviral TPOXX as monkeypox outbreak continues
Biogen and Happify partner on digital support for MS patients

Views & Analysis

cancer care

Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Redefining the approach to cancer care – a mission to improve patient outcomes

, , , , 0 Comment

Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million

X
Redefining the approach to cancer care – a mission to improve patient outcomes
https://pharmaphorum.com/oncology/redefining-the-approach-to-cancer-care-a-mission-to-improve-patient-outcomes/
value of diverse patient representation and engagement

Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers

The value of diverse patient representation and engagement in cancer treatment

, , , , , 0 Comment

To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in

X
The value of diverse patient representation and engagement in cancer treatment
https://pharmaphorum.com/whitepapers/value-of-diverse-patient-representation-and-engagement-cancer/
antibody

Market Access/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis

At ESMO, three studies show promise of antibody-drug conjugates in breast cancer

, , , , , 0 Comment

The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of

X
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
https://pharmaphorum.com/oncology/esmo-three-studies-show-promise-antibody-drug-conjugates-breast-cancer/
Human microbiome

Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Understanding the microbiome as an ‘overlooked critical organ’

, , , , 0 Comment

Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there

X
Understanding the microbiome as an ‘overlooked critical organ’
https://pharmaphorum.com/r-d/understanding-the-microbiome-as-an-overlooked-critical-organ/
kidney

Oncology/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Putting patient perspectives at the heart of kidney cancer research

, , , , , , 0 Comment

Commissioned by Ipsen. Ipsen’s Steven Hildemann looks at how we can harness the power of patient perspectives in

X
Putting patient perspectives at the heart of kidney cancer research
https://pharmaphorum.com/patients/patient-perspectives-kidney-cancer-research/
1 2 3 4 ›»

Login

CONTINUE TO SITE >
X
Close in 10 seconds